Evidence map›Paper›PMID 32624089›Full record

Observational studyJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2020

Tablet-Based Limited Echocardiography to Reduce Sonographer Scan and Decontamination Time during the COVID-19 Pandemic.

Sean R McMahon, Garrett De Francis, Sara Schwartz, William L Duvall, Bhaskar Arora, David I Silverman

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multimodality Cardiac Imaging in COVID.Circulation research · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Impact of COVID-19 Pandemic on the Role of Cardiac Sonographers.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Impact of Focused Echocardiography on Scan Time and Diagnostic Quality in Patients with COVID-19.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2020
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sean R McMahonHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut. Electronic address: sean.mcmahon@hhchealth.org.
Garrett De FrancisHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut.
Sara SchwartzHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut.
William L DuvallHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut.
Bhaskar AroraHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut.
David I SilvermanHartford Hospital Division of Cardiology and Heart and Vascular Institute, Hartford, Connecticut.
Hartford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited assessments with handheld ultrasound have found meaningful clinical use in the care of acutely ill patients. However, there are limited data on incorporating handheld-based limited echocardiography into the echocardiography laboratory. The purpose of this study was to assess the efficacy of limited handheld tablet echocardiography as an alternative to traditional echocardiography during the coronavirus disease 2019 (COVID-19) pandemic as a means to limit exposure while providing essential clinical information.

methodsNinety consecutive inpatients with known or suspected COVID-19 were scanned according to laboratory COVID-19 guidelines using a limited 11- to 20-clip protocol on a tablet sonograph. The primary assessment was length of study time. Comparison data were drawn from comprehensive echocardiographic examinations ordered on intensive care patients not under COVID-19 precautions.

resultsOver a 36-day time period, a total of 91 requests were deemed to be appropriate for echocardiography on patients with suspected or confirmed COVID-19 (average age, 67 years; 64% men; mean body mass index, 32 kg/m

conclusionsLimited handheld echocardiography can be successfully implemented in the echocardiography laboratory for screening of COVID-19-related cardiac conditions. The protocol performed with handheld tablet ultrasound provides adequate diagnostic information of major cardiac complications of COVID-19 while decreasing sonographer contact and simplifying decontamination.

Indexed as

BetacoronavirusComputers, HandheldAgedConnecticutCoronavirus InfectionsCOVID-19DecontaminationDisease Transmission, InfectiousEchocardiographyEquipment DesignFemaleFollow-Up StudiesHeart DiseasesHumansIncidenceMaleCOVID-19Handheld echocardiographyLimited echocardiography

Identifiers

PMID32624089
PMCPMC7211571
OpenAlexW3022663832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.